2025-12-28 - Analysis Report
Here's a comprehensive analysis of Northrop Grumman (NOC) based on the provided data:

**0) Overall Performance and Comparison:**

*   **NOC:** Northrop Grumman Corp is a global aerospace and defense technology company.
*   **NOC Cumulative Return:** 49.81%
*   **VOO (S&P 500) Cumulative Return:** 103.21%
*   **Divergence:** -53.4 (Relative Divergence: 5.2)
*   **Interpretation:** NOC has significantly underperformed the S&P 500 over the tracked period. The divergence is quite large, indicating a substantial difference in investment returns. The relative divergence of 5.2 suggests that the current divergence is near the lower end of its historical range.

**1) Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 46.0% | 65.6% | 17.0% | 0.0 | 43.9 |
| 2016-2018  | -2.0% | 74.3% | -17.0% | 0.0 | 35.1 |
| 2017-2019  | 17.0% | 79.2% | -5.0% | 0.9 | 49.2 |
| 2018-2020  | -28.0% | 79.9% | -52.0% | 0.8 | 43.6 |
| 2019-2021  | 43.0% | 79.9% | -4.0% | 0.8 | 55.4 |
| 2020-2022  | 18.0% | 79.9% | 19.0% | 0.3 | 78.1 |
| 2021-2023  | 24.0% | 82.7% | 23.0% | 0.2 | 67.0 |
| 2022-2024  | -15.0% | 82.7% | -36.0% | 0.2 | 67.2 |
| 2023-2025  | -1.0% | 82.1% | -68.0% | 0.1 | 82.7 |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** Fluctuates significantly, ranging from -28.0% to 46.0%.
*   **MDD (Maximum Drawdown):** Consistently high, indicating substantial risk or volatility in returns.
*   **Alpha:** Shows periods of both outperformance (positive alpha) and underperformance (negative alpha) relative to the market.  The recent Alpha is very negative.
*   **Beta:** Generally below 1, suggesting NOC is less volatile than the overall market. Beta trending downwards in recent years.
*   **Cap(B) (Capitalization in Billions):** Shows growth over time, but with some fluctuations.

**2) Recent Stock Price Fluctuations:**

*   **Current Price:** $577.37
*   **Previous Close:** $582.35
*   **Change:** -0.86
*   **5-day SMA:** 578.58
*   **20-day SMA:** 563.55
*   **60-day SMA:** 580.01

**Analysis:**

*   The current price is below both the 5-day and 60-day SMAs, but above the 20-day SMA. This might indicate a potential short-term downtrend after a recent upward move, but further monitoring is needed. The recent price movement shows a slight decrease.

**3) Market Risk Indicators and Expected Return:**

*   **MRI (Market Risk Indicator):** 1.0 (High Investment Recommended)
*   **RSI (Relative Strength Index):** 66.52
*   **PPO (Percentage Price Oscillator):** 0.55
*   **Hybrid Signal:** Buy 100% of cash (4 shares), suggesting a bullish outlook based on the algorithm. Dividend yield of 2.31% and a small monthly investment is recommended.
*   **Recent Divergence Change:** Negative, suggesting a short-term decline.
*   **Expected Return:** -151.2% (Negative), suggesting underperformance compared to the S&P 500 if invested long-term.

**Analysis:**

*   The high MRI suggests a favorable environment for investment, but this contrasts with the negative expected return and recent divergence change. The RSI is nearing overbought territory (above 70), suggesting that the price may be due for a correction.

**4) Recent News & Significant Events:**

*   **Mixed Sentiment:** The news articles present a mixed picture. Some analysts see upside potential, while others suggest a rating downgrade and question if it's too late to invest after a strong price rally.
*   **Analyst Activity:** Voya Investment Management LLC sold shares, which could indicate concerns or profit-taking.
*   **Technical Analysis:** DailyForex suggests potential for more gains based on chart analysis.
*   **Seeking Alpha:** Suggests buying at undervaluation (rating downgrade).

**4-2) Analyst Opinions**

*   **Consensus:** Buy (2.04 on a scale of 1-5)
*   **Target Price:** Average $662.68, with a high of $770 and a low of $533.
*   **Rating Changes:** No information on recent rating changes is provided.

**Analysis:**

*   Analysts, on average, have a "Buy" rating for NOC, suggesting they believe the stock price will increase. The average target price indicates potential upside from the current price.

**5) Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2025-10-21 | 7.69 | $10.42B      |
| 2025-07-22 | 8.17 | $10.35B      |
| 2025-04-22 | 3.33 | $9.47B       |
| 2024-10-24 | 7.02 | $10.00B      |
| 2025-10-21 | 7.02 | $10.00B      |

**Analysis:**

*   **EPS (Earnings Per Share):** Fluctuates significantly, with a low in April 2025. It peaked in July 2025.
*   **Revenue:** Generally stable, around $10 Billion per quarter, except for the dip in April 2025.
*   **Inconsistency:** The table includes two entries for 2025-10-21 with different EPS values. This is likely an error. Assuming the first 2025-10-21 entry is correct, there is a general upward trend in EPS and revenue.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $10.42B | 21.37% |
| 2025-06-30 | $10.35B | 21.35% |
| 2025-03-31 | $9.47B | 16.69% |
| 2024-12-31 | $10.69B | 18.08% |
| 2024-09-30 | $10.00B | 21.07% |

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $15.99B | 6.88% |
| 2025-06-30 | $15.47B | 7.59% |
| 2025-03-31 | $14.98B | 3.21% |
| 2024-12-31 | $15.29B | 8.27% |
| 2024-09-30 | $14.75B | 6.96% |

**Analysis:**

*   **Revenue:** Similar to the Earnings data, revenue is relatively stable with some fluctuations.
*   **Profit Margin:** Profit margins are strong, consistently above 16%, but were lower in early 2025.
*   **Equity:** Equity is increasing, showing growth in the company's net assets.
*   **ROE (Return on Equity):** ROE fluctuates, indicating changes in the profitability of shareholders' equity, with a lower ROE at the beginning of 2025.

**7) Comprehensive Analysis:**

*   **Underperformance:** NOC has significantly underperformed the S&P 500, with a substantial negative divergence.
*   **Mixed Signals:** The technical indicators and market risk indicator suggest a possible buy opportunity, but this is contrasted by a negative expected return and recent negative divergence change.
*   **Analyst Opinion:** Analysts are generally bullish, with a "Buy" consensus and a positive target price.
*   **Financial Health:** NOC appears financially stable with increasing revenue, strong profit margins, and growing equity.
*   **Inconsistent Earnings Data:** There is an inconsistency in the earnings data, which raises questions about the accuracy of the provided information.
*   **Conflicting News:** The news articles show conflicting sentiments, suggesting investors should be cautious and do their own research before making any investment decisions.
*   **Potential for Volatility:** The high maximum drawdown figures highlight the potential for volatile price swings.

**Conclusion:**

Investing in Northrop Grumman presents a complex picture. While analysts and some indicators suggest potential upside, the underperformance relative to the S&P 500, recent negative divergence change, and mixed news sentiment warrant caution. Investors should carefully consider their risk tolerance, investment horizon, and perform further due diligence before investing in NOC. It appears that while the company itself is financially sound, market conditions and sector-specific challenges may be impacting its stock performance.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.